Capitalworks Emerging Markets Acquisition CORP
Market Movers (8-K)
OID
Piermont Valley Acquisition Corp. announced a definitive business combination agreement with Tigerless Health, Inc., an insurtech company, valuing Tigerless Health at approximately $280 million.
Capital raise
OID
Piermont Valley Acquisition Corp entered a non-redemption agreement with a shareholder to retain 200,000 Class A ordinary shares, aiding its business combination extension.
Delay expected
OID
Piermont Valley Acquisition Corp. announced a $1 million non-interest bearing loan from Valleypark Road, LLC and a change in its independent registered public accounting firm from Marcum LLP to Aloba, Awomolo & Partners.
Worse than expected
Capital raise
OID
Piermont Valley Acquisition Corp, a special purpose acquisition company, announced a significant change in control and management, including the transfer of shares and warrants, and the appointment of a new CEO and Chairman, Wei Qian.
Delay expected
OID
8-K: Piermont Valley Acquisition Corp. Secures Shareholder Approval for Extension and Charter Amendments
Piermont Valley Acquisition Corp. (formerly Capitalworks Emerging Markets Acquisition Corp) successfully obtained shareholder approval to extend its business combination deadline to March 3, 2026, and amend its charter.
Delay expected
OID
Capitalworks Emerging Markets Acquisition Corp. enters into a non-redemption agreement to extend its initial business combination deadline to March 3, 2026.
Quarterly Earnings (10-Q)
OID
Piermont Valley Acquisition Corp. reports significant net losses, a going concern warning, and a material financial reporting contradiction in its latest 10-Q filing.
Worse than expected
Capital raise
Delay expected
OID
Piermont Valley Acquisition Corp. reports a net loss and significant liquidity concerns, raising substantial doubt about its ability to continue as a going concern despite a sponsor transition and debt forgiveness.
Delay expected
Worse than expected
Capital raise
OID
Piermont Valley Acquisition Corp. reports a significant net loss and substantial doubt about its ability to continue as a going concern, with its trust account fully depleted after multiple shareholder redemptions.
Delay expected
Worse than expected
Capital raise
Annual Reports (10-K)
OID
Piermont Valley Acquisition Corp, a blank check company, filed its annual 10-K report, detailing multiple business combination extensions, a terminated merger, and Nasdaq delisting.
Delay expected
Capital raise
Worse than expected
Insider Trading (Form 4)
OID
Piermont Valley Acquisition Corp. announced a definitive agreement to merge with Tigerless Health, Inc., an insurtech company, valuing the combined entity at approximately $280 million.
Capital raise
OID
Form 4: Piermont Valley Acquisition Corp Undergoes Sponsor Handover with Share Transfer to New Sponsor
Vikasati Partners LLC, a key insider, transferred a significant portion of its Class A and Class B ordinary shares in Piermont Valley Acquisition Corp to a new sponsor, Valleypark Road, LLC, as part of a sponsor handover.
Proxy Statements (Def-14A)
OID
Piermont Valley Acquisition Corp. is seeking shareholder approval to extend its deadline for completing a business combination by one year to March 3, 2027, following multiple prior extensions and significant redemptions.
Delay expected
Capital raise
Worse than expected
Schedule 13D - Activist Investments
OID
Valleypark Road, LLC has acquired a significant beneficial ownership stake, totaling 85.9% of Class A ordinary shares, in Piermont Valley Acquisition Corp through a purchase agreement with Vikasati Partners, LLC.
OID
Vikasati Partners LLC, a major shareholder in Piermont Valley Acquisition Corp, has transferred a substantial portion of its Class A and Class B ordinary shares to Valleypark Road, LLC, a new sponsor, alongside the cancellation of private placement warrants.